Abstract CT112: AI-powered and Manual Assessment of PD-L1 Are Comparable in Predicting Response to Neoadjuvant Atezolizumab in Patients (pts) with Resectable Non-Squamous, Non-Small Cell Lung Cancer (NSCLC)John Abel,Christopher Rivard,Filip Kos,Guillaume Chhor,Yi Liu,Jennifer Giltnane,Sara Hoffman,Murray Resnick,Cyrus Hedvat,Amaro Taylor-Weiner,Farah Khalil,Alan Nicholas,Gregory A. Fishbein,Lynette M. Sholl,Natasha Rekhtman,Stephanie Hennek,Ilan Wapinski,Ann Johnson,Michael Montalto,Katja Schulze,Bruce E. Johnson,David P. Carbone,Konstantin Shilo,Andrew H. Beck,Sanja Dacic,William D. Travis,Ignacio WistubaCancer Research（2022）引用 0|浏览25AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
